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Background and Aims: Previous studies demonstrated that energy metabolism
disturbance impairs cardiac function and chronic intermittent hypobaric hypoxia (CIHH)
protects heart against ischemia/reperfusion injury. The present study aimed to test the
hypothesis that CIHH protects the heart against ischemia/reperfusion (I/R) injury via
improvement of cardiac glucose metabolism.
Methods: Male Sprague-Dawley rats received CIHH treatment simulating 5000-m
altitude for 28 days, 6 h per day in a hypobaric chamber or no treatment (control). Body
weight, fasting blood glucose, blood lipid and glucose tolerance were measured. The left
ventricular function of isolated hearts was evaluated during 30 min of ischemia and 60
min of reperfusion using Langendorff method. ThemRNA and protein expression involved
in cardiac energy metabolism was determined using quantitative PCR and Western blot
techniques.
Results: 1. There was no difference of body weight, fast blood glucose, blood lipid
and glucose tolerance between control and CIHH rats under baseline condition (p >
0.05). 2. The recovery of left ventricular function after I/R was improved significantly in
CIHH rats compared to control rats (p < 0.05). 3. The expression of cardiac GLUT4 and
PGC-1α was increased but PDK4 gene expression was decreased by CIHH treatment
at both mRNA and protein level. Also p-AMPK/AMPK ratio was increased in CIHH rats
(p < 0.05).
Conclusion: CIHH ameliorates I/R injury through improving cardiac glucose metabolism
via upregulation of GLUT4, p-AMPK, and PGC-1α expressions, but downregulation of
cardiacPDK4 expression.
Keywords: chronic intermittent hypobaric hypoxia, cardiac protection, ischemia/reperfusion, glucosemetabolism,
PGC-1α, rat
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INTRODUCTION
It is well known that cardiovascular disease is the leading cause
of mortality, morbidity, and health care costs globally (Fernando
et al., 2015). To date, only limited success has been achieved
in preventing and treating ischemic heart diseases (Bu et al.,
2015). The normal structure and function of the heart depend on
stabilization of energy metabolism. Disturbed energy supply or
altered energy substrate utilization has been found to be closely
correlated with cardiac patho-physiological conditions, leading
to impaired cardiac function, such as increased susceptibility to
ischemia-reperfusion (I/R) injury or impaired function recovery
after I/R (Anzawa et al., 2007; Harmancey et al., 2013). Therefore,
optimization of cardiac energy metabolism provides a strategy to
protect against ischemic heart disease.
It has been shown that chronic intermittent hypobaric
hypoxia (CIHH), similar to ischemic preconditioning and high
altitude hypoxia adaptation, confers cardiac protection against
ischemia/reperfusion (I/R) injury in rats (Zhou et al., 2013,
2015; Ma et al., 2014; Bu et al., 2015). The CIHH-induced
cardiac protection persists longer than ischemic preconditioning
and is associated with fewer side effects, such as polycythemia,
right ventricular hypertrophy and pulmonary hypertension
compared with long-term adaptation to high-altitude hypoxia
(Neckar et al., 2004; Zhang and Zhou, 2012; Bu et al., 2015).
Multiple mechanisms and pathways may be involved in the
cardio-protective effect of CIHH, such as increased activity
and expression of antioxidative enzyme (Balkova et al., 2011),
activation of an ATP-sensitive potassium channel and inhibition
of the mitochondrial permeability transition pore opening (Bu
et al., 2015), increase in myocardial capillary density and
coronary blood flow (Zhong et al., 2002), attenuation of beta-
adrenergic receptor activity (Guan et al., 2010), induction of heat
shock protein 70 expression (Zhong et al., 2000), activation of
protein kinase C, and enhancement of resistance against calcium
overload (Chen et al., 2013; Ma et al., 2014).
Although abundant data are available concerning the effects
of CIHH on the myocardium, the research on CIHH is more
concentrated on heart hemodynamics, electrophysiology, and
cell apoptosis, etc. The mechanisms of its protective effect,
especially the mechanisms of energy metabolism, have not yet
been clearly elucidated. The aim of present study is to investigate
if glucose metabolism participates in the cardiac protection of
CIHH by using functional, morphological, biochemical, and
molecular biological methods.
METHODS
CIHH Treatment
All animal experiments were conducted in compliance with the
Guide for the Care and Use of Laboratory Animals (Publication
85–23, revised 1996; National Institutes of Health, Bethesda,
MD), and all techniques and procedures were reviewed and
approved by Hebei Medical University Institutional Animal
Care and Use Committee. Age- and body-weight-matched male
Sprague–Dawley rats (supplied by Hebei Medical University
Animal Center) were randomly divided into control group and
CIHH group (subjected to a hypobaric hypoxia mimicking 5000-
m altitude for 28 days, 6 h per day in a hypobaric chamber where
PB = 404 mmHg, PO2 = 84 mmHg). The control rats were
housed in same environment as CIHH rats but without CIHH
exposure. All animals had free access to water and a standard
laboratory diet and were housed in a temperature-controlled
room (22 ± 1◦C) with a 12 h/12 h light/dark cycle. Body weight
of rats was collected each week.
Blood Glucose and Blood Lipid
Determination
Rats were fasted overnight and were sacrificed the next day
between 9:00 and 12:00 a.m. after blood samples were collected
from the abdominal artery under anesthesia (n = 6 per
group). Blood glucose was measured by glucose meter (ROCHE,
Germany) immediately after blood sampling. The plasma was
separated by centrifuge and stored at −20◦C until analysis.
Plasma concentrations of total cholesterol, triglycerides and non-
esterified fatty acids were measured with commercially available
kits.
Glucose Tolerance Test
Animals were fasted overnight and then intraperitoneally
injected with glucose (50% solution; 2 g/kg body weight). Blood
samples were taken at 0- (before injection), 30-, 60-, and 120-
min after glucose injection. Plasma glucose was determined as
described above. Glucose tolerance was assessed with the area
under the blood glucose curve (AUC), which was calculated
according to the equation below:
AUC = (blood glucose at 0-min + blood glucose at 30-min)
× 0.25 + (blood glucose at 30-min + blood glucose at 60-
min) × 0.25 + (blood glucose at 60-min + blood glucose at
120-min)× 0.5.
Measurement of Ventricular Functions in
Isolated Rat Hearts
The rats were anesthetized with sodium pentobarbital (50
mg/kg) and their hearts were quickly removed and placed
in ice-cold Krebs-Henseleit buffer containing (in mmol/L):
NaCl 118.0, KCl 4.7, CaCl2 2.5, MgSO4 1.2, NaHCO3 25.0,
KH2PO4 1.2, and glucose 11.0 (gassed with 95% O2 and 5%
CO2, pH adjusted to 7.4). Then the hearts were retrogradely
perfused via the aorta with Krebs-Henseleit buffer at constant
pressure (10 kPa) and temperature (37◦C) on a Langendorff
apparatus (Chengdu Instrument, Sichuan, China). A water-filled
latex balloon-tipped catheter was placed into the left ventricle
through the left atrium and adjusted to a left ventricular end
diastolic pressure (LVEDP) of 3–10 mmHg during the initial
equilibration. The distal end of the catheter was connected to
a PowerLab system via a pressure transducer (MLT0380/D, AD
Instrument Ltd., Australia). After 20 min stabilization with K-
H buffer, the hearts subjected to 30 min no-flow global ischemia
followed by 60 min reperfusion. For myocardial infarction
determination, the reperfusion time for the heart was prolonged
to 120 min. Left ventricular developed pressure (LVDP), LVEDP,
maximum rate of rise of left ventricular developed pressure
(+LVdp/dtmax), and maximum rate of decline of left ventricular
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developed pressure (−LVdp/dtmax) were continuously recorded
by PowerLab system (AD Instrument Ltd, Australia). The
data were analyzed by Chart software (AD Instrument,
Australia).
Determination of Myocardial Infarct Size
The isolated rat heart was subjected to 30 min of ischemia
and then followed by 120 min of reperfusion. At the end of
reperfusion, the heart was removed quickly and frozen in−20◦C.
The frozen heart was cut into about 1.5 mm thin slices, which
were perpendicular to the septum from the apex to the base.
Then the slices were incubated in sodium phosphate buffer
containing 1% (wt/vol) 2,3,5-triphenyl tetrazolium chloride
(TTC) for 10 min to visualize the unstained infarct region.
The infarct myocardium that was not stained by TTC looked
pale. Microphotography was taken with a digital camera. The
image processing system (Motic MED 6.0, Xiamen, China)
was used to analysis the data by setting a reference value,
and the software could automatically select the similar region
for the infarct size. The extent of infarct myocardium was
expressed as the percentage of the infarct size to the ventricular
size.
RNA Isolation and Quantitative Real-Time
PCR
Heart tissues used for RNA isolation were rapidly excised and
frozen in liquid nitrogen. RNA was extracted from heart samples
by using TRIzol reagent (Invitrogen, USA) method following
manufactory’s protocol. The integrity of total RNA was assessed
using Nano Drop 2000 Spectrophotometer (Thermo, USA).
Total RNA was reverse transcribed by Invitrogen 2-step RT
kits Superscript II first strand synthesis kit (Invitrogen, USA)
according to the manufacturer’s instructions.
The cDNA was 1:20 diluted and used for real-time
PCR. Platinum SYBR Green qPCR Super Mix-UDG with
ROX kits (Invitrogen, USA) were used to measure gene
expression using specific primer sets: pdk4, glut4, ampk, pgc-
1α, and gapdh (Invitrogen, USA) (Table 1). Dissociation curves
were run following Real-Time PCR reactions to ensure the
detection of the desired amplicon and exclude the presence
of contaminating products. All reactions were performed in
the ABI Prism 7000 Sequence Detection System (Applied
Biosystems, USA). Gene expression was normalized to gapdh
and the data were analyzed using comparative 2∧ − 11Ct
method.
Western Blot
Heart tissues used for western blot were rapidly excised and
frozen in liquid nitrogen. Proteins from heart tissue were
extracted in lysis buffer containing 50 mM Tris-HCl (pH: 8.0)
and complete protease inhibitor cocktail tablet. After protein
quantification, fifty micrograms of total protein extracts from rat
heart tissue were electrophoresed through polyacrylamide SDS
gels and transferred by electroblotting onto PVDF membranes.
Membranes were blocked for 1 h in 5% (w/v) nonfat milk
before incubation with appropriate dilutions of antibodies
of PDK4 (1:1500, Proteintech, USA), CPT1B (1:1000, Aviva
TABLE 1 | The sequences of primers used for Real-time PCR.
Gene Forward primer Reverse primer
ampk 5-TCCCGTGTTTACAGATGT
AGTCG-3
5-AAGATTCGCAGTTTAGATGTT
GTTG-3
gapdh 5-GGACCAGGTTGTCTCC
TGTG-3
5-ATTCGAGAGAAGGGAG
GGCT-3
glut4 5-TCAAAGATGCTGGTTGAATAGT
AGAA-3
5-GATGAGAAACGGAAGTTGG
AAAG-3
pdk4 5-CGACAGATTCTTTGGTTCCTT
ACTT-3
5-CCCCTTTGGCTGGTTTTGG
TTAC-3
pgc-1α 5-GAATGCAGCGCTCTTAGC-3 5-GCTTTTGCTGTTGACA
AATG-3
Systems Biology, USA), AMPKα1 (1:1000, Empitomics, USA),
Phospho-AMPK alpha (Thr 172) (1:1000, Affbiotech, USA),
PGC-1α (1:100, Biorbyt, UK), GLUT4 (1:1000, Empitomics,
USA), GAPDH (1:5000, Empitomics, USA) at 4◦C overnight
and then with corresponding secondary antibodies (1:5000).
The blots were developed using the ECL system (immobilion
TM Western, Millipore) and were analyzed by Quantity One
Software (Bio-Rad, USA). Protein contents were normalized by
glyceraldehyde-3-phosphate dehydrogenase (GAPDH, Abcam,
USA) level.
Data Analysis
Data were expressed as mean ± SD. Student-Newman-
Keuls T-test was used for comparison between two groups.
One-way ANOVA followed by SNK test were used for
multiple comparisons. P < 0.05 was considered statistically
significant.
RESULTS
The Effect of CIHH on Body Weight,
Glucose Concentration, Lipid
Concentration, and Glucose Tolerance Test
There was no difference of body weight, fast blood glucose and
glucose tolerance between control and CIHH rats (P >0.05).
There was no significant difference of blood TG, TC and
nonesterified fatty acid between CON and CIHH rats (P > 0.05,
Figure 1).
The Effects of CIHH on Ventricular
Function and Cardiac Infarct Size
Under baseline conditions, the coronary flow (CF) was
significantly higher in CIHH rats than in CON rats. However,
the basal left ventricular functions indicated by LVDP,
±LVdp/dtmax, and LVEDP did not differ between CON
and CIHH rats. The LVDP and ±LVdp/dtmax were decreased,
whereas LVEDP was increased during I/R, suggesting the left
ventricular function was impaired by I/R. However, the recovery
of cardiac function and CF after I/R was improved in CIHH rats
compared with control rats (P < 0.05 or P < 0.01, Figure 2).
The myocardial infarct size of CIHH rats was also decreased
compared with CON rats (P < 0.01, Figure 2).
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FIGURE 1 | Effects of CIHH on body weight, blood glucose, Triglyceride (TG), Cholesterol (CHO), nonesterified fatty acid, and glucose tolerance in
rats. Data are expressed as the mean ± SD (n = 6 for each group).
FIGURE 2 | Effect of chronic intermittent hypobaric hypoxia on cardiac function and infarct size in isolated rat hearts subjected to 30 min of global
ischemia followed by 60 min of reperfusion. LVDP, Left ventricular developing pressure; LVEDP, left ventricular end-diastolic pressure; +LVdp/dtmax, maximum
rate of rise of left ventricular developed pressure; −LVdp/dtmax, maximum rate of decline of left ventricular developed pressure; CF, coronary flow. Data are expressed
as the mean ± SD (n = 6 for each group). *P < 0.05, **P < 0.01 vs. corresponding CON group.
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The Effects of CIHH on mRNA Expression
Involved in Cardiac Energy Metabolism
To further determine the mechanisms responsible for the
protective effect of CIHH on myocardial energy metabolism
during I/R, gene expression involved in cardiac energy
metabolism was determined using quantitative PCR. After I/R,
the mRNA expression of ampk, pgc-1α and glut4 in myocardium
was increased, while pdk4 was decreased in both CIHH and
control rats. CIHH increased cardiac pgc-1α, and glut4, but
decreased pdk4 mRNA expression more significantly than
CON group (P < 0.05, Figure 3). Meanwhile, ampk mRNA
expression not differ between the two groups (P > 0.05,
Figure 3).
The Effects of CIHH on Protein Expression
Involved in Cardiac Energy Metabolism
Protein expression involved in cardiac energy metabolism
was determined using Western blot. The results showed
that CIHH significantly increased cardiac p-AMPK/AMPK
ratios, PGC-1α, and GLUT4 expression, but decreased
PDK4 protein expression compared to CON group (P
< 0.05, Figures 4, 5). There was no difference of AMPK
protein expression between two groups (P > 0.05, Figure 4).
Furthermore, there were no differences of AMPK, PDK4,
PGC-1α, and GLUT4 expression between before and
after I/R in both CON and CIHH groups (P > 0.05,
Figures 4, 5).
DISCUSSION
In this study, we investigated the role of energy metabolism in
cardiac protection of CIHH. The results showed that there was no
difference between control and CIHH rats in body weight, fasting
blood glucose, blood lipid, and glucose tolerance under basic
condition. Consistent with previous studies (Zhang et al., 2007),
we confirmed again that CIHH improves the recovery of cardiac
function after I/R. Furthermore, CIHH significantly increased the
expression of cardiac PGC-1α and GLUT4, but decreased PDK4
at both mRNA and protein level. In addition, CIHH significantly
increased the ratio of p-AMPK/AMPK protein expression. We
demonstrated for the first time that CIHH ameliorates cardiac
I/R-induced injury by increasing GLUT4, p-AMPK, and PGC-1α
expression, but reducing PDK4 expression in cardiomyocytes.
The constant workload of the heart requires a continuous
energy supply in the form of adenosine triphosphate (ATP)
to maintain its contractile function. However, the myocardial
storage of ATP is insufficient, and must be synthesized
continuously. ATP may come from a variety of energy substrate,
such as fatty acids, sugars and metabolic products such as lactic
acid, pyruvic acid and ketone. Among the myocardial substrates,
FIGURE 3 | Effect of CIHH on gene expression of cardiac ampk, pdk4, glut4, and pgc-1α using Realtime PCR. Data are expressed as the mean ± SD (n =
6 in each group). *P < 0.05, **P < 0.01 vs. corresponding CON group; #P < 0.05, ##P < 0.01 vs. corresponding pre-ischemia.
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FIGURE 4 | Effect of CIHH on the protein expression of AMPK, p-AMPK, PDK4 and PGC-1α in left ventricular myocytes before and after I/R. (A) Protein
expression of AMPK and p-AMPK; (B) Protein expression of PDK4; (C) Protein expression of PGC-1α. CON, control group; CIHH, chronic intermittent hypobaric
hypoxia; Pre, pre-ischemia; I/R, ischemia/reperfusion. Data are expressed as the mean ± SD (n = 6 in each group). *P < 0.05 vs. corresponding CON group.
glucose accounts for less than 25% of the energy production
under normal conditions. However, glucose is unique among
myocardial substrates because a small amount of ATP is obtained
by substrate-level phosphorylation during glycolysis even in
situations of hypoxia or ischemia. ATP obtained from glycolysis
in the extramitochondrial compartment, although scarce, may
be of paramount importance for the maintenance or restoration
of ionic homeostasis (Montessuit and Lerch, 2013). It has been
found that diabetic heart, characterized by reduced glucose
oxidation, is more prone to I/R injury (Anzawa et al., 2007;
Harmancey et al., 2013). Cardiac function recovery after I/R was
improved by partial stimulation of glucose oxidation (Gandhi
et al., 2008; Lucchinetti et al., 2011; Nagendran et al., 2013).
Therefore, improvement of myocardial cell glucose metabolism
could increase the heart’s tolerance to ischemic injury (Finck and
Kelly, 2007; Li et al., 2010; Rowe et al., 2010).
The first step of glucose metabolism is the transport of
glucose across the plasma membrane. Glucose transport occurs
by facilitated diffusion through selective transport proteins of
the GLUT family. In cardiomyocytes, mostly two isoforms of
glucose transporter, GLUT1 and GLUT4, are involved. GLUT1
predominates during fetal and early postnatal life (Montessuit
and Lerch, 2013). GLUT4, on the other hand, is the main isoform
presented in fully differentiated cardiomyocytes. GLUT4 has a
higher affinity for glucose than GLUT1, which makes GLUT4
responsible for the majority of glucose uptake (Montessuit and
Lerch, 2013). It was reported that augmented glucose uptake by
GLUT4 displayed a protective effects during cardiac ischemia
in neonatal or adult mice (Shi et al., 2016) and normal or
streptozotocin (STZ)-treated diabetic rats (Ji et al., 2013). Our
study showed that CIHH increased cardiac GLUT4 expression
at both mRNA and protein levels, indicating that CIHH may
improve glucose metabolism through increase of cardiac glucose
uptake.
Before glucose enters the oxidative pathways of the
mitochondrion, it must first undergo anaerobic metabolism
in the cytosol of the cardiac myocyte and be converted to
pyruvate. Then pyruvate can be converted to lactate outside
the mitochondrion or oxidized in the mitochondrial matrix to
generate acetyl-CoA by the action of pyruvate dehydrogenase
(PDH) for the tricarboxylic acid cycle (Finck and Kelly, 2007)
and ATP was produced. PDH, a rate-limiting enzyme in
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FIGURE 5 | Effect of CIHH on the protein expression of GLUT4 in left
ventricular myocytes before and after I/R. CON, control group; CIHH,
chronic intermittent hypobaric hypoxia; Pre, pre-ischemia; I/R,
ischemia/reperfusion. Data are shown as expressed as the mean ± SD (n = 6
in each group). *P < 0.05 vs. corresponding CON group.
glucose oxidation, is inhibited by PDH kinase-4 (PDK-4). PDH
inhibition leads to reduction of glucose oxidation and diversion
of glycolytic intermediates to alternative metabolic pathways.
Some studies displayed that decrease of PDK4 could improve
the glucose metabolism (Gao et al., 2014, 2015) and contribute
to protection against I/R injury. In the present study, CIHH
reduced PDK4 expression at both mRNA and protein levels,
indicating that CIHH may improve glucose metabolism through
increase of cardiac glucose oxidation by decrease of PDK-4.
PGC-1s proteins, including PGC-1α, PGC-1β, and PGC-
1–related coactivator, enhance the transcriptional activity of
transcription factors through direct protein-protein interactions.
PGC-1α is highly inducible in response to increased demand
for myocardial ATP productionand acts as an important energy
regulator in the heart (Lu et al., 2010; Leone and Kelly, 2011).
PGC-1α gene expression is also sensitive to metabolic sensors
such as adenosine monophosphate-activated protein kinase
(AMPK). The expression of PGC-1α is repressed in numerous
models of heart failure, and has been indicated as an important
contributor to the maladaptive energetic profile of failing hearts
(Rowe et al., 2010). Mice lacking PGC-1α develop signatures of
heart failure with a marked drop in cellular ATP concentration.
The expression of PGC-1α and its targets is downregulated
in pathological cardiac hypertrophy and failing heart (Finck
and Kelly, 2007). However, moderate overexpression of PGC-
1α contributes to the protective effect of cardiomyocytes (Rowe
et al., 2010; Liu et al., 2015), which could be elucidated by the
regulation of the glucose uptake and oxidation (Finck and Kelly,
2006). Our study showed that CIHH increased the expression
of PGC-1α both mRNA and protein, suggesting PGC-1α could
improve the glucose uptake and oxidation, which may improve
the energy metabolism of the cardiomyocytes and reduce the I/R
injury in rat heart.
AMPK is the key factor in the heart that orchestrating the
cellular response to a variety of stresses and regulates metabolism
and organelle function. Recent investigations have shed light
on the cardio-protective role of AMPK in I/R injury as well
as in pathological hypertrophy and failure (Gundewar et al.,
2009; Gauthier et al., 2011; Kim and Tian, 2011). AMPK can be
activated by phosphorylation of the Thr172 site, sensing the fuel
shift and then phosphorylate and activate downstream targeting
genes such as FoxO and PGC-1α (Jager et al., 2007; Greer
et al., 2009). Therefore, increased expression of AMPK, especially
phosphorylated AMPK (p-AMPK) may contribute to protecting
the heart against I/R injury. In our study, CIHH did not affect
the expression of AMPK, but the protein expression of p-AMPK
and p-AMPK/AMPK ratios increased. The results indicate that
CIHH enhances the activation of AMPK, which contributes to
the cardiac protection against I/R injury.
In conclusion, this study demonstrated for the first time that
CIHH protects the heart against I/R injury through improvement
of the energy metabolism via upregulating cardiac GLUT4, p-
AMPK, and PGC-1α expressions and downregulating cardiac
PDK4 expression, which will provide a new concept or strategy
for prevention and treatment of ischemic heart disease.
AUTHOR CONTRIBUTIONS
Designed the experiments: HM; performed the experiments: XL,
YG, YC, YT; analyzed the data: YL; wrote the manuscript: XL;
revised the manuscript: HM, YZ.
ACKNOWLEDGMENTS
This study was supported by the National Natural Sciences
Foundation of China (No. 81200070, 81100607, 31211120166),
the National Basic Research Development Program of China
(No. 2012CB518200) and Natural Science Foundation of Hebei
Province (H2015206512).
REFERENCES
Anzawa, R., Seki, S., Horikoshi, K., Taniguchi, M., and Mochizuki, S.
(2007). Exacerbation of acidosis during ischemia and reperfusion
arrhythmia in hearts from type 2 Diabetic Otsuka Long-Evans
Tokushima Fatty rats. Cardiovasc. Diabetol. 6, 17. doi: 10.1186/1475-28
40-6-17
Balkova, P., Hlavackova, M., Milerova, M., Neckar, J., Kolar, F., Novak, F., et al.
(2011). N-acetylcysteine treatment prevents the up-regulation of MnSOD in
chronically hypoxic rat hearts. Physiol. Res. 60, 467–474.
Bu, H. M., Yang, C. Y., Wang, M. L., Ma, H. J., Sun, H., and Zhang, Y. (2015).
K(ATP) channels and MPTP are involved in the cardioprotection bestowed by
chronic intermittent hypobaric hypoxia in the developing rat. J. Physiol. Sci. 65,
367–376. doi: 10.1007/s12576-015-0376-5
Frontiers in Physiology | www.frontiersin.org 7 June 2016 | Volume 7 | Article 219
Li et al. Cardioprotection of CIHH via Enhancement of Glucose Metabolism
Chen, S. M., Lin, H. Y., and Kuo, C. H. (2013). Altitude training improves glycemic
control. Chin. J. Physiol. 56, 193–198. doi: 10.4077/CJP.2013.BAB130
Fernando, E., Razak, F., Lear, S. A., and Anand, S. S. (2015). Cardiovascular
Disease in South Asian Migrants. Can. J. Cardiol. 31, 1139–1150. doi:
10.1016/j.cjca.2015.06.008
Finck, B. N., and Kelly, D. P. (2006). PGC-1 coactivators: inducible regulators
of energy metabolism in health and disease. J. Clin. Invest. 116, 615–622. doi:
10.1172/JCI27794
Finck, B. N., and Kelly, D. P. (2007). Peroxisome proliferator-activated
receptor gamma coactivator-1 (PGC-1) regulatory cascade in
cardiac physiology and disease. Circulation 115, 2540–2548. doi:
10.1161/CIRCULATIONAHA.107.670588
Gandhi, M., Finegan, B. A., and Clanachan, A. S. (2008). Role of glucose
metabolism in the recovery of postischemic LV mechanical function: effects of
insulin and other metabolic modulators.Am. J. Physiol. Heart Circ. Physiol. 294,
H2576–H2586. doi: 10.1152/ajpheart.00942.2007
Gao, S., McMillan, R. P., Jacas, J., Zhu, Q., Li, X., Kumar, G. K., et al. (2014).
Regulation of substrate oxidation preferences in muscle by the peptide
hormone adropin. Diabetes 63, 3242–3252. doi: 10.2337/db14-0388
Gao, S., McMillan, R. P., Zhu, Q., Lopaschuk, G. D., Hulver, M. W., and Butler,
A. A. (2015). Therapeutic effects of adropin on glucose tolerance and substrate
utilization in diet-induced obese mice with insulin resistance. Mol. Metab. 4,
310–324. doi: 10.1016/j.molmet.2015.01.005
Gauthier, M. S., O’brien, E. L., Bigornia, S., Mott, M., Cacicedo, J. M., Xu, X. J.,
et al. (2011). Decreased AMP-activated protein kinase activity is associated with
increased inflammation in visceral adipose tissue and with whole-body insulin
resistance in morbidly obese humans. Biochem. Biophys. Res. Commun. 404,
382–387. doi: 10.1016/j.bbrc.2010.11.127
Greer, E. L., Banko, M. R., and Brunet, A. (2009). AMP-activated protein kinase
and FoxO transcription factors in dietary restriction-induced longevity. Ann.
N.Y. Acad. Sci. 1170, 688–692. doi: 10.1111/j.1749-6632.2009.04019.x
Guan, Y., Gao, L., Ma, H. J., Li, Q., Zhang, H., Yuan, F., et al. (2010). Chronic
intermittent hypobaric hypoxia decreases beta-adrenoceptor activity in right
ventricular papillary muscle. Am. J. Physiol. Heart Circ. Physiol. 298, H1267–
H1272. doi: 10.1152/ajpheart.00410.2009
Gundewar, S., Calvert, J. W., Jha, S., Toedt-Pingel, I., Ji, S. Y., Nunez, D., et al.
(2009). Activation of AMP-activated protein kinase by metformin improves left
ventricular function and survival in heart failure. Circ. Res. 104, 403–411. doi:
10.1161/CIRCRESAHA.108.190918
Harmancey, R., Vasquez, H. G., Guthrie, P. H., and Taegtmeyer, H. (2013).
Decreased long-chain fatty acid oxidation impairs postischemic recovery of the
insulin-resistant rat heart. FASEB J. 27, 3966–3978. doi: 10.1096/fj.13-234914
Jager, S., Handschin, C., St-Pierre, J., and Spiegelman, B. M. (2007). AMP-activated
protein kinase (AMPK) action in skeletal muscle via direct phosphorylation
of PGC-1alpha. Proc. Natl. Acad. Sci. U.S.A. 104, 12017–12022. doi:
10.1073/pnas.0705070104
Ji, L., Zhang, X., Liu, W., Huang, Q., Yang, W., Fu, F., et al. (2013). AMPK-
regulated and Akt-dependent enhancement of glucose uptake is essential in
ischemic preconditioning-alleviated reperfusion injury. PLoS ONE 8:e69910.
doi: 10.1371/journal.pone.0069910
Kim, M., and Tian, R. (2011). Targeting AMPK for cardiac protection:
opportunities and challenges. J. Mol. Cell. Cardiol. 51, 548–553. doi:
10.1016/j.yjmcc.2010.12.004
Leone, T. C., and Kelly, D. P. (2011). Transcriptional control of cardiac fuel
metabolism and mitochondrial function. Cold Spring Harb. Symp. Quant. Biol.
76, 175–182. doi: 10.1101/sqb.2011.76.011965
Li, Y. J., Wang, P. H., Chen, C., Zou, M. H., andWang, D.W. (2010). Improvement
of mechanical heart function by trimetazidine in db/db mice. Acta Pharmacol.
Sin. 31, 560–569. doi: 10.1038/aps.2010.31
Liu, X. P., Gao, H., Huang, X. Y., Chen, Y. F., Feng, X. J., He, Y. H., et al. (2015).
Peroxisome proliferator-activated receptor gamma coactivator 1 alpha protects
cardiomyocytes from hypertrophy by suppressing calcineurin-nuclear factor
of activated T cells c4 signaling pathway. Transl. Res. 166, 459–473 e453. doi:
10.1016/j.trsl.2015.06.003
Lu, Z., Xu, X., Hu, X., Fassett, J., Zhu, G., Tao, Y., et al. (2010). PGC-1 alpha
regulates expression of myocardial mitochondrial antioxidants and myocardial
oxidative stress after chronic systolic overload. Antioxid. Redox Signal. 13,
1011–1022. doi: 10.1089/ars.2009.2940
Lucchinetti, E., Wang, L., Ko, K. W., Troxler, H., Hersberger, M., Zhang, L.,
et al. (2011). Enhanced glucose uptake via GLUT4 fuels recovery from
calcium overload after ischaemia-reperfusion injury in sevoflurane- but not
propofol-treated hearts. Br. J. Anaesth. 106, 792–800. doi: 10.1093/bja/a
er065
Ma, H. J., Li, Q., Ma, H. J., Guan, Y., Shi, M., Yang, J., et al. (2014).
Chronic intermittent hypobaric hypoxia ameliorates ischemia/reperfusion-
induced calcium overload in heart via Na/Ca2+ exchanger in
developing rats. Cell. Physiol. Biochem. 34, 313–324. doi: 10.1159/0003
63001
Montessuit, C., and Lerch, R. (2013). Regulation and dysregulation of glucose
transport in cardiomyocytes. Biochim. Biophys. Acta 1833, 848–856. doi:
10.1016/j.bbamcr.2012.08.009
Nagendran, J., Pulinilkunnil, T., Kienesberger, P. C., Sung, M. M., Fung, D.,
Febbraio, M., et al. (2013). Cardiomyocyte-specific ablation of CD36 improves
post-ischemic functional recovery. J. Mol. Cell. Cardiol. 63, 180–188. doi:
10.1016/j.yjmcc.2013.07.020
Neckar, J., Ostadal, B., and Kolar, F. (2004). Myocardial infarct size-limiting effect
of chronic hypoxia persists for five weeks of normoxic recovery. Physiol. Res.
53, 621–628.
Rowe, G. C., Jiang, A., and Arany, Z. (2010). PGC-1 coactivators
in cardiac development and disease. Circ. Res. 107, 825–838. doi:
10.1161/CIRCRESAHA.110.223818
Shi, T., Papay, R. S., and Perez, D. M. (2016). alpha1A-Adrenergic receptor
prevents cardiac ischemic damage through PKCdelta/GLUT1/4-mediated
glucose uptake. J. Recept. Signal Transduct. Res. 36, 261–270. doi:
10.3109/10799893.2015.1091475
Zhang, H., Yang, C. Y., Wang, Y. P., Wang, X., Cui, F., Zhou, Z. N., et al.
(2007). Effects of different modes of intermittent hypobaric hypoxia on
ischemia/reperfusion injury in developing rat hearts. Sheng Li Xue Bao 59,
660–666.
Zhang, Y., and Zhou, Z. N. (2012). Beneficial effects of intermittent hypobaric
hypoxia on the body. Zhongguo Ying Yong Sheng Li Xue Za Zhi 28,
504–509.
Zhong, N., Zhang, Y., Fang, Q. Z., and Zhou, Z. N. (2000). Intermittent hypoxia
exposure-induced heat-shock protein 70 expression increases resistance of rat
heart to ischemic injury. Acta Pharmacol. Sin. 21, 467–472.
Zhong, N., Zhang, Y., Zhu, H. F., Wang, J. C., Fang, Q. Z., and Zhou, Z. N. (2002).
Myocardial capillary angiogenesis and coronary flow in ischemia tolerance rat
by adaptation to intermittent high altitude hypoxia. Acta Pharmacol. Sin. 23,
305–310.
Zhou, J. J., Ma, H. J., Liu, Y., Guan, Y., Maslov, L. N., Li, D. P., et al. (2015).
The anti-arrhythmic effect of chronic intermittent hypobaric hypoxia in rats
with metabolic syndrome induced with fructose. Can. J. Physiol. Pharmacol. 93,
227–232. doi: 10.1139/cjpp-2014-0343
Zhou, J. J., Wei, Y., Zhang, L., Zhang, J., Guo, L. Y., Gao, C., et al. (2013).
Chronic intermittent hypobaric hypoxia prevents cardiac dysfunction through
enhancing antioxidation in fructose-fed rats. Can. J. Physiol. Pharmacol. 91,
332–337. doi: 10.1139/cjpp-2012-0059
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Li, Liu, Ma, Guan, Cao, Tian and Zhang. This is an open-access
article distributed under the terms of the Creative Commons Attribution License (CC
BY). The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Physiology | www.frontiersin.org 8 June 2016 | Volume 7 | Article 219
